February 1, 2015 | The Australian-owned medical cannabis company PhytoTech Medical Limited has appointed Dr. Daphna Heffetz as CEO of the subsidiary company in Israel. As CEO of the company, Dr. Heffetz hopes to lead the development and commericalization of high potential cannabis-based therapeutic products, together with the technological transfer company of the Hebrew University, Yissum. PhytoTech Medical was the first medical cannabis company to list on Australia’s ASX market, and has research facilities in Israel.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
UK Adopts Israeli Counter-Drone Technology
April 25, 2024
Top Tel Aviv Hospital Using AI In Neurological Therapy
April 18, 2024
Facebook comments